Institutional investors purchased a net $55.7 thousand shares of ALBO during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 4.34% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OPALEYE MANAGEMENT, INC. Bought 36.5 Thousand shares of Albireo Pharma Inc
SECTORAL ASSET MANAGEMENT, INC. Bought 20.2 Thousand shares of Albireo Pharma Inc
SEGANTII CAPITAL MANAGEMENT LTD. Bought 2.1 Thousand shares of Albireo Pharma Inc